- In February 2025, Medidata Solutions, a leading provider of clinical trial technology, announced the launch of its new AI-powered Clinical Trial Management System designed to enhance data integration and real-time analytics. The system offers improved trial monitoring capabilities, automated risk assessments, and streamlined regulatory compliance workflows, aimed at accelerating drug development timelines and improving trial efficiency
- In November 2024, Oracle Corporation unveiled the latest version of its CTMS platform with enhanced cloud-based features, including advanced patient recruitment tools, remote monitoring support, and integrated eConsent modules. These innovations are intended to support decentralized and hybrid clinical trials, improving participant engagement and data accuracy
- In October 2024, IQVIA Inc. introduced its next-generation CTMS solution incorporating machine learning algorithms to predict trial risks and optimize resource allocation. The platform also provides real-time dashboards and customizable reports to improve decision-making for clinical research organizations (CROs) and sponsors
- In August 2024, Clario announced an expansion of its CTMS offerings with integrated electronic data capture (EDC) and patient-reported outcomes (PRO) modules. This unified system aims to simplify data management, enhance compliance, and improve patient-centric trial designs. The updated platform targets improved operational efficiency and regulatory readiness
